.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Medtronic
Mallinckrodt
UBS
Citi
McKinsey
Baxter
Federal Trade Commission
Merck

Generated: September 20, 2017

DrugPatentWatch Database Preview

Phentermine resin complex - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentermine resin complex and what is the scope of phentermine resin complex patent protection?

Phentermine resin complex
is the generic ingredient in three branded drugs marketed by Ucb Inc, Quantum Pharmics, and Lannett Holdings Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for phentermine resin complex. One supplier is listed for this compound.

Summary for Generic Name: phentermine resin complex

Tradenames:3
Patents:0
Applicants:3
NDAs:3
Drug Master File Entries: see list17
Suppliers / Packagers: see list1
Bulk Api Vendors: see list20
Clinical Trials: see list1,563
Patent Applications: see list4,754
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:phentermine resin complex at DailyMed

Pharmacology for Ingredient: phentermine resin complex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Holdings Inc
PHENTERMINE RESIN COMPLEX
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL040872-002Jul 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
IONAMIN
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL011613-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
PHENTERMINE RESIN COMPLEX
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL040872-001Jul 28, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
PHENTERMINE RESIN 30
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL089120-001Feb 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
IONAMIN
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL011613-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Teva
Boehringer Ingelheim
McKinsey
Federal Trade Commission
Novartis
Deloitte
Healthtrust
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot